World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
50
Citations
8117
World Ranking
3943
National Ranking
7

Anton Buzdin publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Anton Buzdin sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 210 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Anton Buzdin D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Anton Buzdin sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 50 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Anton Buzdin is affiliated with Sechenov University in the Russian Federation and has a significant body of research primarily within the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their work spans a total of 221 publications in these main fields, with a particular focus on Molecular Biology, Cancer Research, and Oncology among subfields.

The scientist's recent publications include a range of topics addressing cancer research and molecular biology techniques. Notable papers are:

  • FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients (2021, Frontiers in Oncology)
  • Spatial transcriptomics: Technologies, applications and experimental considerations (2023, Genomics)
  • Differences between human and chimpanzee genomes and their implications in gene expression, protein functions and biochemical properties of the two species (2020, BMC Genomics)
  • The Role of the Metabolism of Zinc and Manganese Ions in Human Cancerogenesis (2022, Biomedicines)
  • Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma (2020, Cancers)

Anton Buzdin frequently collaborates with several researchers, including:

  • Maxim Sorokin
  • Maria Suntsova
  • Marianna Zolotovskaia
  • Andrew Garazha
  • Elena Poddubskaya

Among publication venues, they have contributed most often to:

  • International Journal of Molecular Sciences (12 publications)
  • Frontiers in Oncology (8 publications)
  • Biomedicines (6 publications)
  • Cancers (6 publications)
  • Biochemistry (Moscow) (6 publications)

Anton Buzdin's research addresses key topics such as:

  • Bioinformatics and Genomic Networks
  • Cancer Genomics and Diagnostics
  • RNA modifications and cancer
  • Molecular Biology Techniques and Applications
  • RNA and protein synthesis mechanisms
  • Gene expression and cancer classification
  • Lung Cancer Treatments and Mutations

In addition to articles, they have published books with Frontiers Media, including:

  • Application and Innovation of Multiomics Technologies in Clinical Oncology (2023)
  • Insights in Cancer Genetics and Oncogenomics: 2022 (2023)

Best Publications

  • Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs.

    Marianna A. Zolotovskaia;Maxim I. Sorokin;Anna A. Emelianova;Nikolay M. Borisov

  • Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death

    Bridget Larkin;Vladimir Ilyukha;Maxim Sorokin;Anton Buzdin

  • Genetics and epigenetics of aging and longevity

    Alexey A Moskalev;Alexander M Aliper;Zeljka Smit-McBride;Anton Buzdin

  • Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis

    Joseph Sarhan;Beiyun C. Liu;Hayley I. Muendlein;Chi G. Weindel

  • Retroelements and their impact on genome evolution and functioning

    Elena Gogvadze;Anton Buzdin

  • In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development.

    Ivan V. Ozerov;Ksenia V. Lezhnina;Evgeny Izumchenko;Artem V. Artemov

  • FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients

    Ye Wang;Zhuang Tong;Wenhua Zhang;Weizhen Zhang

  • The human genome contains many types of chimeric retrogenes generated through in vivo RNA recombination

    Anton Buzdin;Elena Gogvadze;Elena Kovalskaya;Pavel Volchkov

  • A new family of chimeric retrotranscripts formed by a full copy of U6 small nuclear RNA fused to the 3' terminus of l1.

    Anton Buzdin;Svetlana Ustyugova;Elena Gogvadze;Tatiana Vinogradova

  • At Least 50% of Human-Specific HERV-K (HML-2) Long Terminal Repeats Serve In Vivo as Active Promoters for Host Nonrepetitive DNA Transcription

    Anton Buzdin;Elena Kovalskaya-Alexandrova;Elena Gogvadze;Eugene Sverdlov

  • Human-specific subfamilies of HERV-K (HML-2) long terminal repeats: three master genes were active simultaneously during branching of hominoid lineages.

    Anton Buzdin;Svetlana Ustyugova;Konstantin Khodosevich;Ilgar Mamedov

  • Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data

    Anton A. Buzdin;Alex A. Zhavoronkov;Mikhail B. Korzinkin;Larisa S. Venkova

  • Atlas of RNA sequencing profiles for normal human tissues.

    Maria Suntsova;Nurshat Gaifullin;Daria Allina;Alexey Reshetun

  • Molecular functions of human endogenous retroviruses in health and disease.

    Maria Suntsova;Andrew Garazha;Alena Ivanova;Dmitry Kaminsky

  • Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH.

    Maria Suntsova;Elena V. Gogvadze;Sergey Salozhin;Nurshat Gaifullin

  • Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs.

    Anton Buzdin;Maxim Sorokin;Andrew Garazha;Marina Sekacheva

  • Signaling pathways activation profiles make better markers of cancer than expression of individual genes

    Nikolay M. Borisov;Nadezhda V. Terekhanova;Alexander M. Aliper;Larisa S. Venkova

  • Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells

    Alexander M. Aliper;Antonei Benjamin Csoka;Anton Buzdin;Tomasz Jetka

  • H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 Histone Tags Suggest Distinct Regulatory Evolution of Open and Condensed Chromatin Landmarks.

    Anna A. Igolkina;Arsenii Zinkevich;Kristina O. Karandasheva;Aleksey A. Popov

  • Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling

    P V Spirin;T D Lebedev;N N Orlova;N N Orlova;A S Gornostaeva;A S Gornostaeva

Frequent Co-Authors

Olga Kovalchuk
Olga Kovalchuk University of Lethbridge
Mario A. Ostrowski
Mario A. Ostrowski University of Toronto
Charles R. Cantor
Charles R. Cantor Boston University
David Sidransky
David Sidransky Johns Hopkins University School of Medicine
Christian Hartmann
Christian Hartmann Hannover Medical School
Gerhard Hunsmann
Gerhard Hunsmann University of Göttingen
Zoltán Ivics
Zoltán Ivics Paul Ehrlich Institut
Pierre-Alain Clavien
Pierre-Alain Clavien University of Zurich
Marc-Henri Lebrun
Marc-Henri Lebrun University of Paris-Saclay
Katherine A. Fitzgerald
Katherine A. Fitzgerald University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in genetics opens doors to a wide range of opportunities in healthcare and biomedical fields. For those interested in exploring related career pathways, there are several online degrees and certifications that serve as valuable stepping stones.

Many students pursue a medical billing and coding course to gain foundational knowledge in healthcare documentation and administration. This is a practical option for individuals seeking quick entry into the healthcare sector.

If you are interested in patient care, researching what is the easiest nursing program to get into can help you begin a rewarding career as a nurse with a less competitive application process.

Consider management and leadership roles by enrolling in an accelerated healthcare administration degree online. These programs are ideal for those seeking rapid advancement.

For budget-conscious students, a healthcare administration degree can be completed online at an affordable rate, offering flexibility for working professionals.

With these online pathways, you can complement your genetics knowledge and pursue diverse roles in today’s healthcare industry.

Best Scientists Citing Anton Buzdin

Trending Scientists

Recently Published Articles